Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Baxter
Covington
Fuji
McKinsey
UBS
Mallinckrodt
Cerilliant
Fish and Richardson

Generated: July 18, 2018

DrugPatentWatch Database Preview

CYSVIEW KIT Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Cysview Kit patents expire, and what generic alternatives are available?

Cysview Kit is a drug marketed by Photocure Asa and is included in one NDA. There is one patent protecting this drug.

This drug has ten patent family members in eight countries.

The generic ingredient in CYSVIEW KIT is hexaminolevulinate hydrochloride. One supplier is listed for this compound. Additional details are available on the hexaminolevulinate hydrochloride profile page.
Drug patent expirations by year for CYSVIEW KIT
Generic Entry Opportunity Date for CYSVIEW KIT
Generic Entry Date for CYSVIEW KIT*:
Constraining patent/regulatory exclusivity:
ADDITIONAL INFORMATION ADDED TO THE LABELING FROM STUDY PC B308/13 REGARDING THE USE OF BLUE LIGHT CYSTOSCOPY WITH CYSVIEW AS AN ADJUNCT TO WHITE LIGHT CYSTOSCOPY
NDA:
Dosage::
FOR SOLUTION;INTRAVESICAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Synonyms for CYSVIEW KIT
140898-91-5
5-amino-4-oxopentanoic acid hexyl ester hydrochloride
5-Aminolevulinic acid hexyl ester hydrochloride
5-Aminolevulinic acid hexylester hydrochloride
6842AA
898A915
A-6140
AC1O5FJ4
AK-59194
AKOS016002051
ala hexyl ester hydrochloride
AM84373
aminolevulinc acid hexyl ester
aminolevulinic acid hexyl ester hydrochloride
AN-31604
ANW-58882
AX8102340
C11H22ClNO3
CHEMBL1201785
CS-5206
CTK8B7894
Cysview
Cysview (TN)
D04436
D0AY9Q
D4F329SL1O
DB-063352
delta-aminolevulinic acid hexyl ester hydrochloride
DTXSID80161486
FT-0767765
Hexaminolevulinate (hydrochloride)
hexaminolevulinate HCl
Hexaminolevulinate Hydrochloride
Hexaminolevulinate hydrochloride (USAN)
Hexaminolevulinate Hydrochloride [USAN]
Hexaminolevulinate hydrochloride, >=98% (HPLC)
HexvisR
Hexvix
Hexvix (TN)
hexyl 5-amino-4-oxo-pentanoate hydrochloride
Hexyl 5-amino-4-oxopentanoate hydrochloride
hexyl aminolevulinate
HY-16045
LZYXPFZBAZTOCH-UHFFFAOYSA-N
MFCD03695491
MolPort-016-582-410
n-hexyl 5-aminolevulinate hydrochloride
OR1924
P 1206
P-1026
P-1206
Pentanoic acid, 5-amino-4-oxo-, hexyl ester, hydrochloride
SCHEMBL937621
TC-147627
UNII-D4F329SL1O
ZX-AT022126

US Patents and Regulatory Information for CYSVIEW KIT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Photocure Asa CYSVIEW KIT hexaminolevulinate hydrochloride FOR SOLUTION;INTRAVESICAL 022555-001 May 28, 2010 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Photocure Asa CYSVIEW KIT hexaminolevulinate hydrochloride FOR SOLUTION;INTRAVESICAL 022555-001 May 28, 2010 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for CYSVIEW KIT

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Photocure Asa CYSVIEW KIT hexaminolevulinate hydrochloride FOR SOLUTION;INTRAVESICAL 022555-001 May 28, 2010 ➤ Try a Free Trial ➤ Try a Free Trial
Photocure Asa CYSVIEW KIT hexaminolevulinate hydrochloride FOR SOLUTION;INTRAVESICAL 022555-001 May 28, 2010 ➤ Try a Free Trial ➤ Try a Free Trial
Photocure Asa CYSVIEW KIT hexaminolevulinate hydrochloride FOR SOLUTION;INTRAVESICAL 022555-001 May 28, 2010 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Accenture
Baxter
Cerilliant
Fuji
US Army
Johnson and Johnson
Merck
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.